National implementation of a race-neutral eGFR equation contributed to more modifications and higher kidney transplantation rates for Black candidates, according to study data published in the Journal ...

ChemDiv, a global provider of integrated drug discovery solutions, today announced kinase inhibitor design enhancements to its discovery platform. The new capabilities strengthen support for partners ...

Genmab will acquire Merus in a deal worth almost $8 billion for access to an EGFR × LGR5 bispecific called petosemtamab. The antibody is currently in two phase III trials in patients with head and ...

A team has devised a more accurate way of measuring an indicator of kidney function known as glomerular filtration rate (GFR) by taking aging into account. Annual health checkups regularly include ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

Initial results of a Phase 1 / 2 open label study of AT-02, the company’s lead pan-amyloid removal therapeutic candidate, in patients with AL amyloidosis will be presented at ASH.The presentation ...

Aumolertinib and osimertinib showed similar efficacy and safety in treating EGFR-mutant NSCLC, with no significant differences in progression-free survival or overall survival. The study involved 202 ...

Democratic nominee Zohran Mamdani is giving New Yorkers a chance to see how much cash they would save under his administration -- if he's able to make good on his campaign promises. Mamdani has found ...

After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to ...